Non Hodgkin Lymphoma News and Research

RSS
Millennium, Seattle Genetics' new brentuximab vedotin trial data presented at ASCO 2011

Millennium, Seattle Genetics' new brentuximab vedotin trial data presented at ASCO 2011

Data from Seattle Genetics' brentuximab vedotin, SGN-75 programs to be presented at ASCO 2011

Data from Seattle Genetics' brentuximab vedotin, SGN-75 programs to be presented at ASCO 2011

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN

Millennium submits two VELCADE sNDAs to FDA

Millennium submits two VELCADE sNDAs to FDA

Research on rare cancers

Research on rare cancers

Study reveals few genes involved with lymphoma shared by dogs and humans

Study reveals few genes involved with lymphoma shared by dogs and humans

Keryx KRX-0401 data in colorectal cancer, multiple myeloma presented at AACR meeting

Keryx KRX-0401 data in colorectal cancer, multiple myeloma presented at AACR meeting

Aeterna Zentaris presents two posters on perifosine at AACR meeting

Aeterna Zentaris presents two posters on perifosine at AACR meeting

Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return

Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return

Groundbreaking discovery in lymphoma research

Groundbreaking discovery in lymphoma research

Night shift work may reduce risk of skin cancer in women

Night shift work may reduce risk of skin cancer in women

Millennium, Seattle commence brentuximab vedotin phase I trial in patients with ALCL

Millennium, Seattle commence brentuximab vedotin phase I trial in patients with ALCL

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

Researchers to develop computer-assisted diagnosis tools for pathologists

Researchers to develop computer-assisted diagnosis tools for pathologists

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Cell Medica enters EBV-associated cancer research collaboration with CAGT and Baylor College of Medicine

Therapies to target self-renewing population of chemotherapy-resistant cells needed

Therapies to target self-renewing population of chemotherapy-resistant cells needed

New ways to identify patients most likely to respond to cancer vaccine treatment

New ways to identify patients most likely to respond to cancer vaccine treatment

No overall cancer risk in people who donate stem cells

No overall cancer risk in people who donate stem cells